Works matching IS 10538569 AND DT 2022 AND VI 31 AND IP 5
Results: 14
Effectiveness and use of reverse transcriptase polymerase chain reaction point of care testing in a large‐scale COVID‐19 surveillance system.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 5, p. 511, doi. 10.1002/pds.5424
- By:
- Publication type:
- Article
Stability of individual dementia diagnoses in routine care: Implications for epidemiological studies.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 5, p. 546, doi. 10.1002/pds.5416
- By:
- Publication type:
- Article
Validation of diagnostic coding for interstitial lung diseases in an electronic health record system in Hong Kong.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 5, p. 519, doi. 10.1002/pds.5421
- By:
- Publication type:
- Article
Management of epilepsy in Lebanon: Medication reviews and drug‐related problems.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 5, p. 583, doi. 10.1002/pds.5409
- By:
- Publication type:
- Article
Sex differences in the utilization of drugs for COVID‐19 treatment among elderly residents in a sample of Italian nursing homes.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 5, p. 489, doi. 10.1002/pds.5420
- By:
- Publication type:
- Article
Evolving channeling in prescribing SGLT‐2 inhibitors as first‐line treatment for type 2 diabetes.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 5, p. 566, doi. 10.1002/pds.5406
- By:
- Publication type:
- Article
Validity of identification algorithms combining diagnostic codes with other measures for acute ischemic stroke in MID‐NET®.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 5, p. 524, doi. 10.1002/pds.5423
- By:
- Publication type:
- Article
Utility of fertility procedures and prenatal tests to estimate gestational age for live‐births and stillbirths in electronic health plan databases.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 5, p. 534, doi. 10.1002/pds.5414
- By:
- Publication type:
- Article
The impact of regulatory restrictions on pregabalin use in Saudi Arabia: An interrupted time series analysis.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 5, p. 577, doi. 10.1002/pds.5408
- By:
- Publication type:
- Article
Background rates of five thrombosis with thrombocytopenia syndromes of special interest for COVID‐19 vaccine safety surveillance: Incidence between 2017 and 2019 and patient profiles from 38.6 million people in six European countries.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 5, p. 495, doi. 10.1002/pds.5419
- By:
- Publication type:
- Article
Population‐based prevalence of polypharmacy and patterns of medication use in southwestern Iran: A cross‐sectional study.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 5, p. 592, doi. 10.1002/pds.5418
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 5, p. 1, doi. 10.1002/pds.5498
- Publication type:
- Article
Issue Information.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 5, p. 604, doi. 10.1002/pds.5275
- Publication type:
- Article
Impact on In‐ and Out‐of‐Hospital Drug Prescriptions of Including a More Expensive Me‐Too Antidepressant in a Hospital Drug Formulary: a Controlled Longitudinal Study.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 5, p. 556, doi. 10.1002/pds.5405
- By:
- Publication type:
- Article